Stella Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The following discussion and analysis should be read together with our financial statements and the related notes appearing elsewhere in this Annual Report. This discussion contains forward-looking... | March 29, 2023

GARDEN CITY, NY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented and diversified diagnostics,...

Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer - read this article along with other careers information, tips and advice on BioSpace

Stella Diagnostics, Inc.: Stella Diagnostics Announces Completion of Corporate Name and Ticker Symbol Changes (SLDX) SALT LAKE CITY, UT / ACCESSWIRE / April 16, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") announced today that its corporate name change from "JMP Properties, Inc." to "Stella Diagnostics, Inc." became effective on April 16, 2021. In connection with the name change, the Company's common stock will begin trading on the OTC Markets under the ticker symbol "SLDX" at the open of market trading on April 16, 2021. "Stella Diagnostics was founded to impro...

Stella Diagnostics, Inc.: Stella Diagnostics to Present at 23rd Annual ICR Conference SALT LAKE CITY, UT / ACCESSWIRE / January 7, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP), a molecular diagnostics-based organization focused on improving patient management strategies for people living with preneoplastic and cancerous esophageal diseases, today announced that the Company's Chief Executive Officer, Dr. Joe Abdo is scheduled to present at the 23rd Annual ICR Conference to be held virtually January 11-14, 2021. Dr. Abdo will provide a corporate update and participate in a Q&A with registere...